EP2276343A2 - Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the same - Google Patents
Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the sameInfo
- Publication number
- EP2276343A2 EP2276343A2 EP09743817A EP09743817A EP2276343A2 EP 2276343 A2 EP2276343 A2 EP 2276343A2 EP 09743817 A EP09743817 A EP 09743817A EP 09743817 A EP09743817 A EP 09743817A EP 2276343 A2 EP2276343 A2 EP 2276343A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- dialdehyde
- cellulose
- polysaccharide
- water
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 52
- 239000004599 antimicrobial Substances 0.000 title claims abstract description 41
- 229920002085 Dialdehyde starch Polymers 0.000 claims abstract description 177
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 147
- 239000005017 polysaccharide Substances 0.000 claims abstract description 146
- -1 dialdehyde polysaccharide Chemical class 0.000 claims abstract description 140
- 241000700605 Viruses Species 0.000 claims abstract description 56
- 241000894006 Bacteria Species 0.000 claims abstract description 50
- 229920002678 cellulose Polymers 0.000 claims abstract description 40
- 239000001913 cellulose Substances 0.000 claims abstract description 38
- 238000010438 heat treatment Methods 0.000 claims abstract description 38
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 37
- 230000000813 microbial effect Effects 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 25
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 82
- 239000006185 dispersion Substances 0.000 claims description 43
- 235000010980 cellulose Nutrition 0.000 claims description 39
- 239000002245 particle Substances 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 23
- 229920002472 Starch Polymers 0.000 claims description 18
- 235000019698 starch Nutrition 0.000 claims description 18
- 239000008107 starch Substances 0.000 claims description 15
- 241000192125 Firmicutes Species 0.000 claims description 14
- 229920000856 Amylose Polymers 0.000 claims description 11
- 229920000945 Amylopectin Polymers 0.000 claims description 10
- 229920001661 Chitosan Polymers 0.000 claims description 9
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- 229920002307 Dextran Chemical class 0.000 claims description 8
- 230000002792 vascular Effects 0.000 claims description 8
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 229920000615 alginic acid Chemical class 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical class OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 229960002086 dextran Drugs 0.000 claims description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- 229920002971 Heparan sulfate Polymers 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 6
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 6
- 229940045110 chitosan Drugs 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000007943 implant Substances 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 210000003709 heart valve Anatomy 0.000 claims description 4
- 239000004753 textile Substances 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical class C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 3
- 229920002567 Chondroitin Chemical class 0.000 claims description 3
- 229920001287 Chondroitin sulfate Chemical class 0.000 claims description 3
- 229920002558 Curdlan Polymers 0.000 claims description 3
- 239000001879 Curdlan Substances 0.000 claims description 3
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 3
- 229920002527 Glycogen Chemical class 0.000 claims description 3
- 102000011782 Keratins Human genes 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims description 3
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical class OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 claims description 3
- 229920001218 Pullulan Chemical class 0.000 claims description 3
- 239000004373 Pullulan Chemical class 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 239000000783 alginic acid Chemical class 0.000 claims description 3
- 229960001126 alginic acid Drugs 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- 229920013820 alkyl cellulose Polymers 0.000 claims description 3
- 229920003064 carboxyethyl cellulose Polymers 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical class CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 3
- 229940107200 chondroitin sulfates Drugs 0.000 claims description 3
- 229940078035 curdlan Drugs 0.000 claims description 3
- 235000019316 curdlan Nutrition 0.000 claims description 3
- 229940051593 dermatan sulfate Drugs 0.000 claims description 3
- 229960000633 dextran sulfate Drugs 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- 229940096919 glycogen Drugs 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 claims description 3
- 229960002897 heparin Drugs 0.000 claims description 3
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 239000001814 pectin Chemical class 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Chemical class 0.000 claims description 3
- 229960000292 pectin Drugs 0.000 claims description 3
- 239000000770 propane-1,2-diol alginate Chemical class 0.000 claims description 3
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 claims description 3
- 235000019423 pullulan Nutrition 0.000 claims description 3
- 229920001285 xanthan gum Chemical class 0.000 claims description 3
- 206010002329 Aneurysm Diseases 0.000 claims description 2
- 206010021639 Incontinence Diseases 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- 210000004556 brain Anatomy 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 230000000747 cardiac effect Effects 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 230000003073 embolic effect Effects 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 210000005036 nerve Anatomy 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000000527 sonication Methods 0.000 abstract description 25
- 230000002147 killing effect Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 description 31
- 230000001580 bacterial effect Effects 0.000 description 29
- 239000000725 suspension Substances 0.000 description 23
- 150000001299 aldehydes Chemical group 0.000 description 18
- 150000004804 polysaccharides Chemical class 0.000 description 18
- 230000003647 oxidation Effects 0.000 description 17
- 238000007254 oxidation reaction Methods 0.000 description 17
- 239000007900 aqueous suspension Substances 0.000 description 16
- 230000009467 reduction Effects 0.000 description 15
- 238000006722 reduction reaction Methods 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 15
- 239000008187 granular material Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000000840 anti-viral effect Effects 0.000 description 11
- 239000008367 deionised water Substances 0.000 description 11
- 229910021641 deionized water Inorganic materials 0.000 description 11
- 238000005227 gel permeation chromatography Methods 0.000 description 11
- 230000002779 inactivation Effects 0.000 description 11
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical class OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- 239000000123 paper Substances 0.000 description 9
- 241000991587 Enterovirus C Species 0.000 description 8
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 8
- 238000010411 cooking Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 125000003172 aldehyde group Chemical group 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 206010064097 avian influenza Diseases 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000004062 sedimentation Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- LLYCMZGLHLKPPU-UHFFFAOYSA-M perbromate Chemical compound [O-]Br(=O)(=O)=O LLYCMZGLHLKPPU-UHFFFAOYSA-M 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 241001515965 unidentified phage Species 0.000 description 4
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 3
- 208000002979 Influenza in Birds Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 241000450599 DNA viruses Species 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000007068 beta-elimination reaction Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 229910001919 chlorite Inorganic materials 0.000 description 2
- 229910052619 chlorite group Inorganic materials 0.000 description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000013808 oxidized starch Nutrition 0.000 description 2
- 239000001254 oxidized starch Substances 0.000 description 2
- 238000003921 particle size analysis Methods 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 125000000424 1,2-diol group Chemical group 0.000 description 1
- DUIOKRXOKLLURE-UHFFFAOYSA-N 2-octylphenol Chemical compound CCCCCCCCC1=CC=CC=C1O DUIOKRXOKLLURE-UHFFFAOYSA-N 0.000 description 1
- 229920001685 Amylomaize Polymers 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 238000005705 Cannizzaro reaction Methods 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000606678 Coxiella burnetii Species 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000006825 Eastern Equine Encephalomyelitis Diseases 0.000 description 1
- 201000005804 Eastern equine encephalitis Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014587 Encephalitis eastern equine Diseases 0.000 description 1
- 206010014614 Encephalitis western equine Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000589602 Francisella tularensis Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000598171 Human adenovirus sp. Species 0.000 description 1
- 241000342334 Human metapneumovirus Species 0.000 description 1
- 241000711920 Human orthopneumovirus Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023927 Lassa fever Diseases 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 229920002201 Oxidized cellulose Polymers 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000606695 Rickettsia rickettsii Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000005466 Western Equine Encephalomyelitis Diseases 0.000 description 1
- 201000005806 Western equine encephalitis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-N alpha-L-IdopA-(1->3)-beta-D-GalpNAc4S Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940118764 francisella tularensis Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 229940107304 oxidized cellulose Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940075118 rickettsia rickettsii Drugs 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
Definitions
- avian influenza also known as "bird flu”. While the occurrence of bird flu in human individuals has been documented, to date the occurrence of cases in human has been both sporadic, and limited. At present, the transmission of avian influenza from one individual to another has been limited to the avian species. However, experts predict that if avian influenza were ever to cross over to the human species, and become transmitted from human to human, a pandemic of epic proportions could potentially result. Current strategies for the control of a potential infection call for the vaccination of a limited number of first responders, and the quarantine and isolation of a community population for up to two weeks.
- Surgical masks are also considered to be a backup strategy for controlling the transmission rate, since they have the ability to partially remove airborne particles generated by a cough or a sneeze.
- these masks are lacking in their ability to kill any viruses that come in contact with the mask, and as such, viral particles retain their ability to travel into, and subsequently infect, the lungs.
- quarantine strategies would not be effective methods for controlling the spread of the infectious disease.
- MDR-TB multi-drug resistant tuberculosis
- Staphylococcus aureus drug-resistant strains of Staphylococcus aureus
- Dialdehyde polysacchardides are polymeric dialdehydes prepared by the selective oxidation of polysaccharides through the use of periodate salts. Due to the presence of dialdehyde functional groups in the polymer chain, dialdehyde polysaccharides have the ability to react with hydroxyl, amino, imino and sulfhydryl functional groups.
- dialdehyde starch DAS
- the application of DAS to a variety of different and diverse fields has been investigated including paper, leather and textile applications, as well as biomedical applications, for example, the surface modification of stents to improve protein absorption.
- the toxicity of DAS has also been determined in rats and is reported to have an extremely low oral acute toxicity in rats, i.e. an acute LD50 for a 10% DAS aqueous suspension is greater than or equal to 6800 mg/kg (Radley, J.A., Starch Production Technology. 1976, Applied Science Publishers: London).
- dialdehyde polysaccharides While the application of dialdehyde polysaccharides as antimicrobial agents has been investigated to some degree, research into the antimicrobial behavior of dialdehyde polysaccharides has not been fully explored.
- US Patent No. 4,034,084 to Serigusa describes the antimicrobial activity of dialdehyde cellulose granules on select bacterial strains, and discloses that these insoluble granules were able to inhibit the growth of a select number of bacterial strains.
- Disclosed herein is a method of preparing an antimicrobial agent, comprising heating a dialdehyde starch in water at a temperature of about 6O 0 C to about 12O 0 C to form a dispersion of dialdehyde polysaccharide in water.
- an antimicrobial composition comprising a dispersion of a dialdehyde starch in water having a pH of about 2.5 to about 9.
- Disclosed herein too is a method of inhibiting the growth of a microbial agent, the method comprising contacting the microbial agent with a composition comprising a dispersion of dialdehyde starch in water; the dispersion having a pH of about 2.5 to about 9.
- a method of producing an antimicrobial article comprising heating a dialdehyde starch in water at a temperature of about 6O 0 C to about 12O 0 C to form a dispersion of dialdehyde starch in water; sonicating the dispersion of dialdehyde starch in water; and contacting the article with the dispersion of dialdehyde starch in water to form an antimicrobial article.
- composition comprising a dialdehyde polysaccharide; and water; the dialdehyde polysaccharide being dispersed in the water; the dialdehyde polysaccharides having average particle sizes of about 5 to about 150 nanometers.
- article comprising the aforementioned composition.
- a filter comprising a substrate; and a dialdehyde polysaccharide disposed upon the substrate.
- Disclosed herein too is a method comprising oxidizing a cellulose; forming a dialdehyde polysaccharide on a surface of the cellulose; and using the cellulose having the dialdehyde polysaccharide disposed thereon as a filter.
- Figure 1 is a graph illustrating the effect of pH on the log reduction of Gram- negative bacteria following bacterial incubation in PBS at varying pH levels for a period of one hour;
- Figure 2 is a graph illustrating the effect of dialdehyde starch on the log reduction of Gram-negative bacteria following bacterial incubation in dialdehyde starch of varying pH levels for a period of one hour;
- Figure 3 is a graph illustrating the effect of pH on the log reduction of Gram- positive bacteria following bacterial incubation in PBS of varying pH levels for a period of one hour;
- Figure 4 is a graph illustrating the effect of dialdehyde starch on the log reduction of Gram-positive bacteria following bacterial incubation in dialdehyde starch of varying pH levels for a period of one hour
- Figure 5 is a bar graph showing the log reduction in Gram-negative and Gram- positive bacteria observed following bacterial treatment with either dialdehyde starch or PBS, each at a pH of 4.8, for one or four hours;
- Figure 6 is a graph illustrating the effect of DAS sonication on the inactivation of bacteria
- Figure 7 is a graph comparing the effect of either 2.7% dialdehyde starch or PBS having the same pH value, on the log reduction of PRDl virus following treatment for 1 hour or 4 hours;
- Figure 8 is a graph comparing the effect of either 2.7% dialdehyde starch or PBS having the same pH value, on the log reduction of MSDl virus following treatment for 1 hour or 4 hours;
- Figure 9 is a graph comparing the effect of either 2.7% D dialdehyde starch or PBS having the same pH value, on the log reduction of polio virus following treatment for 1 hour or 4 hours;
- Figure 10 depicts structural differences between the dialdehyde starch and the oxidized corn starch;
- Figure 11 (a) is a gel permeation chromatography graph showing the response versus the retention time, while the Figure ll(b) is another gel permeation chromatography graph showing the differential weight fraction versus molecular weight;
- Figure 12 is a graph of absorbance versus wavelength for a dialdehyde starch aqueous suspension; the graph is a spectrum obtained by Fourier Transform Infrared analysis;
- Figure 13 is an Ultraviolet- Visible (UV- Vis) spectrum.
- Figure 13(a) is a UV- Vis spectra of the dialdehyde starch samples taken in the reflectance mode for as- received dialdehyde starch.
- Figure 13(b) is a UV- Vis spectra of the freeze-dried sample of the 3% as-prepared dialdehyde starch aqueous supernatant taken in the reflectance mode.
- Figure 13(d) is a UV- Vis spectra taken in the transmission mode of the 0.3% DAS granular suspension.
- Figure 14 is a schematic diagram of the setup used to measure the efficacy of the dialdehyde polysaccharides as filters.
- first, second, third, and the like may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer or section from another region, layer or section. Thus, a first element, component, region, layer or section discussed below could be termed a second element, component, region, layer or section without departing from the teachings of the present invention.
- microbial agent refers to a microorganism, such as a virus or bacteria.
- the microbial agent may, or may not, be capable of causing morbidity and/or mortality in either humans or animals.
- an “antimicrobial agent” is an agent that has antiviral (kills or suppresses the replication of viruses), or antibacterial (bacteriostatic or bactericidal) properties.
- Polysaccharides as used herein, are biological polymers made up of repeating monosaccharides joined together by glycosidic bonds, and are large, often branched, macromolecules. In biological systems, polysaccharides function as structural components or as energy storage molecules.
- the present disclosure is directed to a method of preparing an antimicrobial agent having both antiviral and antibacterial properties.
- the antimicrobial agent prepared as described herein has the ability to effectively kill Gram-negative and Gram-positive bacteria, as well as bacterial and human viruses, within a period of less than or equal to about 4 hours.
- compositions that comprise the antimicrobial agent.
- antimicrobial agents can be applied to surfaces that can then be used to effectively kill Gram-negative and Gram-positive bacteria, as well as bacterial and human viruses.
- An exemplary article is a filter having a layer of dialdehyde polysaccharides disposed thereon.
- the layer of dialdehyde polysaccharides may be physically extractable from a substrate upon which is it is disposed.
- the layer of dialdehyde polysaccharides may be covalently bonded with the substrate upon which it is disposed and may not be physically separated from the substrate without undergoing some form of physical, chemical or thermal degradation.
- the antimicrobial agent is a dialdehyde polysaccharide that has been subjected to heating and/or sonication in water to produce a dispersion of a dialdehyde polysaccharide in water.
- the dispersion of the dialdehyde polysaccharide in water can have the consistency of a gel-like material.
- the source of the polysaccharide used to prepare the dialdehyde polysaccharide may be from corn, wheat, potato or tapioca starches, celluloses, dextrins, dextrans, algins, insulins and related materials.
- the dialdehyde polysaccharide is prepared from a starch or a cellulose.
- the antimicrobial agent is a dialdehyde polysaccharide selected from the group consisting of a dialdehyde starch (DAS), a dialdehyde cellulose, cellulose, alkyl cellulose, e.g., methyl cellulose, hydroxyalkyl cellulose, alkylhydroxyalkyl cellulose, cellulose sulfate, salts of carboxymethyl cellulose, carboxymethyl cellulose, carboxyethyl cellulose, chitin, carboxymethyl chitin, hyaluronic acid, salts of hyaluronic acid, alginate, alginic acid, propylene glycol alginate, glycogen, dextran, dextran sulfate, curdlan, pectin, pullulan, xanthan, chondroitin, chondroitin sulfates, carboxymethyl dextran, carboxymethyl chitosan, chitosan, heparin, heparin s
- the polysaccharide is oxidized as described herein to assure that the aldehyde-modified polysaccharide is biodegradable.
- the dialdehyde polysaccharide is a dialdehyde starch that has been heated in water and/or sonicated. A portion of the dialdehyde starch solubilizes in the water while a portion remains undispersed. In one embodiment, the undispersed portion can be filtered leaving behind a suspension of the dialdehyde starch in water.
- the dialdehyde polysaccharide is essentially free of functional or reactive moieties other than aldehyde moieties.
- essentially free it is meant that the polysaccharide does not contain such functional or reactive moieties in amounts effective to alter the properties of the dialdehyde polysaccharide.
- Starch is a polysaccharide comprising a mixture of two complex carbohydrate polymers, amylose and amylopectin. Both amylose and amylopectin are polymers of D-glucose units bonded together via alpha-linkages.
- amylose In amylose, the glucose units are linked via ⁇ -1, 4 linkages with the ring oxygen atoms all on the same side, whereas in amylopectin about one glucose unit in every twenty or so repeat units is also linked via an ⁇ -1, 6 linkage, thereby forming branch -points.
- amylose comprises a linear chain of several hundred glucose molecules, while amylopectin is a branched molecule made of several thousand glucose units.
- the ratio of amylose to amylopectin in starch is generally from about 20 to about 30 mole percent amylose, to about 70 to about 80 mole percent amylopectin.
- amylomaizes contain over 50% mole percent amylose whereas "waxy" maize has almost none ( ⁇ 3 mole percent).
- Cellulose is a structural polysaccharide founds in plants, comprising a linear chain of D-glucose.
- the glucose units of cellulose are bonded together via beta- linkages and are held together by intra and inter chain hydrogen bonds.
- cellulose is also insoluble in water.
- the structure of cellulose is generally more crystalline than the structure of starch.
- dialdehyde polysaccharides such as dialdehyde starch or dialdehyde cellulose
- dialdehyde starch or dialdehyde cellulose generally occurs by the selective oxidation of the polysaccharide polymer.
- a variety of oxidizers can be used to oxidize the polysaccharide.
- examples of oxidizers include those selected from the group consisting of alkali, alkaline earth and transition metal salts of, for example, periodate, hypochlorite, perbromate, chlorite, chlorate, hydrogen peroxide, peracetic acid and combinations comprising at least one of the foregoing oxidizers.
- Equation I A reaction depicting the preparation of a dialdehyde polysaccharide by the selective oxidation of starch, is shown in Equation I: Equation I
- Equation 1 the oxidation of starch, results in the addition of two aldehyde groups to individual glucose molecules within the polymer chain.
- the advantage of using periodic acid lies in the specificity of its oxidation. It facilitates the formation of aldehydes within the polysaccharide molecule.
- the extent of oxidation of the polysaccharide polymer can be controlled by, for example, the amount of oxidizer added, the duration of the oxidation process, and/or the temperature of the reaction.
- the oxidation time needed for the oxidation of starch can be attained in about 24 hours. Specifically, at least about 15 percent of the hydroxyl groups are oxidized, and more specifically, about 35 to about 100 percent of the hydroxyl groups are oxidized.
- a method of preparing an antimicrobial agent comprises suspending granules of the dialdehyde polysaccharide (e.g., a dialdehyde starch) in water to form an aqueous dispersion, and heating the dialdehyde polysaccharide for a period of time effective to increase the antimicrobial activity of the dialdehyde polysaccharide. Prior to heating, the dialdehyde polysaccharide is highly granular and insoluble in water.
- the dialdehyde polysaccharide e.g., a dialdehyde starch
- dialdehyde polysaccharide Upon heating, the dialdehyde polysaccharide loses its insoluble nature, resulting in the solubilization of the dialdehyde polysaccharide and the formation of a dispersion of dialdehyde polysaccharide in water having the consistency of a gel-like material.
- the dispersion of dialdehyde polysaccharide in water comprises about 0.2 to about 40 weight percent dialdehyde polysaccharide, specifically about 1 to about 30 weight percent, and more specifically about 2 to about 20 weight percent, based on the total weight of the dialdehyde polysaccharide and water.
- An exemplary amount of dialdehyde polysaccharide in the dispersion of dialdehyde polysaccharide in water is about 3 to about 10 weight percent, based on the total weight of the dialdehyde polysaccharide and water.
- an exemplary dialdehyde polysaccharide for dispersion in water is a dialdehyde starch.
- the viscosity of a dispersion of the dialdehyde polysaccharide in water is about 0.03 to about 0.3 poise, specifically about 0.05 to about 0.2 poise, and more specifically about 0.07 to about 0.1 poise.
- the average particle sizes of the dialdehyde polysaccharide is about 5 nanometers to about 150 nanometers, specifically about 7 to about 100 nanometers, and more specifically about 8 to about 75 nanometers.
- dialdehyde starch In the case of dialdehyde starch, the heating of the dialdehyde starch in water is thought to cause both the swelling of the starch granule and ultimately the loss of granular integrity. The swelling and/or breakdown of the dialdehyde starch molecule results in an overall increase in the number of exposed reactive dialdehydes thereby providing additional reactive groups that are capable of interacting with the microbial agent. In one embodiment, the heating of the dialdehyde starch increases the percentage of dialdehyde reactive groups that are exposed in the dispersion of the dialdehyde starch in water as compared to the number of dialdehyde reactive groups exposed on the granular dialdehyde polysaccharide prior to heating.
- the percentage of reactive dialdehyde groups present in the dispersion of the dialdehyde starch is increased by about 10 to about 50 percent, as compared with the number of reactive dialdehyde groups present on the surface of a granular dialdehyde polysaccharide.
- the method of preparing the antimicrobial agent comprises heating the dialdehyde starch in water for a period of about 1 to about 4 hours at a temperature of about 8O 0 C to about 12O 0 C. Pressures greater than or equal to atmospheric can be used during the heating.
- the dialdehyde starch is heated for a period of about 1.5 to about 3 hours and more specifically, for a period of about 2 to about 2.5 hours.
- the heating of the sample may be conducted using known methods for heating.
- the dialdehyde starch may be mixed during the heating process to ensure the even distribution of heat throughout the suspension. Methods of heating of the dialdehyde starch may be selected from convection, conduction, radiation, or a combination comprising at least one of the foregoing heating methods.
- the method of preparing the antimicrobial agent comprises sonicating the dispersion of the dialdehyde starch in water.
- the dialdehyde starch Prior to or during sonication, the dialdehyde starch may first be heated using the methods described herein. Alternatively, the dialdehyde starch may be left untreated i.e., not heated prior to sonication.
- Another possible alternative comprises first sonicating the dialdehyde starch and then heating the dialdehyde starch as previously described.
- Yet another alternative comprises simultaneously sonicating and heating the dialdehyde starch.
- the dialdehyde starch is subjected to sonication for a period of about 10 minutes to about 3 hours. Specifically, the dialdehyde starch is sonicated for a period of about 15 minutes to about 90 minutes. More specifically, the dialdehyde starch is sonicated for about 30 minutes to about 60 minutes.
- the sonication process may be conducted in a continuous manner for a shorter period of time, or in an intermittent manner, for a longer period of time. Sonication can be conducted at a power of up to about 10 watts to promote the dispersion of the dialdehyde starch in the water.
- the sonication of the dialdehyde starch breaks down the dialdehyde polysaccharide granules into smaller particles.
- the breakdown of the dialdehyde polysaccharide and the generation of smaller particles results in an overall increase in the surface area.
- the increased surface area provides for the exposure of more dialdehyde groups thereby providing additional reactive groups that are capable of interacting with the microbial agent.
- the dialdehyde polysaccharide granules, or particles range in size from about 0.01 micrometers ( ⁇ m) to about 10 millimeters. Following sonication, the size of the dialdehyde particles is about 5 nanometers to about 500 ⁇ m.
- sonication of the particles subsequent to heating acts to further reduce the size of the particles and therefore further increases the surface area available for interaction with the microbial agent(s).
- a portion of dialdehyde polysaccharide granules upon being dispersed into the water are completely solubilized in the water, while a portion may remain in the form of particles.
- up to about 99 weight percent of the dialdehyde polysaccharides may be dispersed in the water during the cooking and/or sonication. In yet another embodiment, up to about 90 weight percent of the dialdehyde polysaccharides may be dispersed in the water during the cooking and/or sonication. In yet another embodiment, up to about 80 weight percent of the dialdehyde polysaccharides may be dispersed in the water during the cooking and/or sonication. In yet another embodiment, about 1 to about 70 weight percent of the dialdehyde polysaccharides may be dispersed in the water during the cooking and/or sonication. The weight percents are based on the sum of the weights of the dialdehyde polysaccharides and water. The remaining portion of the dialdehyde polysaccharides may be retained in the form of particles.
- the particle size of dialdehyde polysaccharide particles after dispersion in water can be about 0.5 nanometers to about 500 micrometers, specifically about 20 nanometers to about 250 micrometers, and more specifically about 50 nanometers to about 100 micrometers.
- Undispersed dialdehyde polysaccharide particles can be separated from the suspension and can be removed. The separation can be effected by filtration, centrifugation, decantation, and the like.
- the antimicrobial agent may comprise up to about 99 weight percent of the dialdehyde starch dispersed in the water.
- the antimicrobial suspension can comprise about 1 to about 90 weight percent, specifically about 3 to about 60 weight percent and more specifically about 5 to about 40 weight percent of the dialdehyde starch that is dispersed in water.
- particle size analysis measured on a Coulter Counter of: 1) a 3% dialdehyde starch "granular" suspension and 2) a dialdehyde starch-aqueous suspension, ("cooked") was almost the same with mean particle sizes of about 0.5 micrometers to about 2 micrometers, specifically 0.7 to about 1.8 micrometers, and more specifically about 0.9 to about 1.5 micrometers. In an exemplary embodiment, the mean particle sizes were about 1.3 micrometers. After centrifuging of 1) and 2), the suspensions both had separated into two phases, an aqueous phase and solid pellet phase.
- a method for inhibiting the growth of a microbial agent by contacting the microbial agent with a composition comprising a dialdehyde polysaccharide that has been heated according to the method described herein. In another embodiment, a method is provided for inhibiting the growth of a microbial agent by contacting the microbial agent with a composition comprising a dialdehyde polysaccharide that has been sonicated.
- the heating and/or sonication of the dispersion of dialdehyde polysaccharide in water is effective to increase both the antibacterial and antiviral activity of the dialdehyde polysaccharide.
- the dialdehyde polysaccharide prepared by the method described herein is able to effectively kill both bacteria and viruses.
- a sterilizing preparation capable of killing viruses and bacteria comprising from about 0.05 to about 5.0 weight percent (wt%) of a dispersion of dialdehyde polysaccharide is capable of killing bacteria and viruses.
- liquid or gel preparations comprising, about 2 to about 3 wt% of a dispersion of active dialdehyde polysaccharide is capable of killing bacteria and viruses.
- a method of inhibiting the growth of a microbial agent using a heated and/or sonicated dialdehyde polysaccharide comprises contacting the dispersion of dialdehyde polysaccharide with the bacteria or virus for a period of time effective to inactivate or kill the bacteria or virus.
- the dialdehyde polysaccharide is effective at killing the microbial agent.
- the terms "killing” or “inhibition” are used interchangeably, and are indicative of the absence of microbial growth and/or replication following contact with the antimicrobial dialdehye polysaccharide.
- the dialdehyde polysaccharide has two closely spaced aldehyde groups (dialdehyde) capable of reacting with hydroxyl, amino, imino, and sulfhydryl groups.
- dialdehyde aldehyde
- the dispersion of dialdehyde polysaccharide is highly effective at cross- linking both microbial proteins as well as microbial nucleic acid.
- the cross-linking of cellular proteins results in the antimicrobial action of the compound, either by causing a release of microbial cell content into the surrounding medium, and/or by interacting with the cell wall of the microbial agent, thereby interfering with the metabolic processes of the organism and causing the killing action.
- a composition comprising the dispersion of dialdehyde polysaccharide is effectively able to inhibit the growth of the microbial agent across a wide range of pH.
- the dialdehyde polysaccharide is effective in killing bacteria and viruses within a pH of about 2.5 to about 9.
- the period of time effective to kill the microbial agent is shorter than the amount of time effective for a dispersion of dialdehyde polysaccharide at a higher pH. That is, at a more neutral or basic pH, the amount of time effective to kill the microbial agent is increased.
- the dialdehyde polysaccharide is effective in killing bacteria and viruses within a pH of about 3 to about 8. In another embodiment, the dialdehyde polysaccharide is effective in killing bacteria and viruses within a pH of about 4 to about 6.
- the period of time effective for the dialdehyde polysaccharide to kill the bacteria or virus ranges from about 0.5 hours to about 10 hours, specifically, from about 1 hour to about 4 hours.
- the period of time effective to kill the bacteria or virus ranges from about 0.5 to about 2 hours, specifically, about 1 hour.
- the period of time effective to kill the microbial agent is about 3 to about 10 hours, specifically, about 4 hours.
- the antimicrobial agent comprising a heated and/or sonicated dialdehyde polysaccharide as described herein, has the ability to inactivate a wide variety of microbial agents.
- the antimicrobial agent is particularly effective against microbial agents that cause morbidity and/or mortality in both humans and animals.
- the microbial agents may be readily transmitted between individuals of the same, and/or different species, or may be opportunistic pathogens, that is, bacterial or viral strains that exploit some break in the host defenses to initiate an infection.
- Examples of microbial agents include viruses, for example single stranded, and double stranded RNA or DNA viruses; Gram-positive bacteria, and Gram-negative bacteria.
- viruses capable of causing morbidity and/or mortality include those selected from the group consisting of influenza virus; encephalitis causing viruses, for example, Eastern and Western equine encephalitis; hemorrhagic fever- causing viruses, for example, Lassa fever, Dengue fever, Ebola virus, and Hantavirus; polioviruses; severe acute respiratory syndrome (SARS)-associated coronavirus; and Hepatitis C.
- influenza virus encephalitis causing viruses, for example, Eastern and Western equine encephalitis
- hemorrhagic fever- causing viruses for example, Lassa fever, Dengue fever, Ebola virus, and Hantavirus
- polioviruses severe acute respiratory syndrome (SARS)-associated coronavirus
- Hepatitis C examples of viruses capable of causing morbidity and/or mortality.
- viruses that can be inactivated by the dispersion of dialdehyde polysaccharide include those that give rise to the common cold such as for example, over 100 serotypes of rhinoviruses (a type of picornavirus), coronavirus, human parainfluenza viruses, human respiratory syncytial virus, adenoviruses, enteroviruses, or metapneumo virus.
- bacterial strains capable of causing morbidity and/or mortality include those selected from the group consisting of drug-resistant Staphylococcus aureus, multi-drug resistant Mycobacterium tuberculosis, Escherichia coli, Salmonella species, for example Salmonella typhi, Pseudomonas aeruginosa, Enterococcus faecalis, Bacillus cereus, Clostridium difficile, Helicobacter pylori, Streptococcus, Group A, Yersinia pestis, Vibrio cholerae, Francisella tularensis, Rickettsia rickettsii, Bacillus anthracis, Coxiella burnetii and Clostridium botulinum.
- drug-resistant Staphylococcus aureus multi-drug resistant Mycobacterium tuberculosis
- Escherichia coli Salmonella species
- Salmonella species for example Salmonella typhi, P
- the antimicrobial agent can be used to disinfect surfaces or articles of manufacture thereby ensuring that the affected surface or article is free from contamination by bacteria and/or viruses.
- the antibacterial agent can also be used to prevent the contamination of surfaces, or articles of manufacture.
- a method of preserving, sanitizing, disinfecting or sterilizing a contaminated surface or area using a composition comprising the antimicrobial agent comprising an effective amount of dialdehyde polysaccharide comprises the steps of contacting the composition with the contaminated surface or area for a period of time effective to preserve, sanitize, disinfect or sterilize the surface or area.
- the antimicrobial agent in one method of disinfecting surfaces, is sprayed onto a surface that is to be disinfected.
- the water from the antimicrobial agent is allowed to evaporate, leaving a film of dialdehyde polysaccharide (e.g., dialdehyde starch) on the surface.
- the film of dialdehyde polysaccharide can kill any bacteria or virus that come into contact with the surface.
- the antimicrobial agent can be used in the form of an aerosolized spray.
- the film can have a thickness of about 10 nanometers to about 500 micrometers, specifically about 20 nanometers to about 250 micrometers, and more specifically about 30 nanometers to about 100 micrometers.
- the dialdehyde polysaccharide that is dispersed in water can be precipitated in the form of a fine powder.
- the precipitation can be brought about by freeze drying, or by the addition of a liquid (that is not compatible with the dialdehyde polysaccharide) to the suspension of dialdehyde polysaccharide in water.
- the powder can then be applied to parts of the body (e.g., the armpits, groins, and the like) or to other surfaces where disinfection is desired. Powder particles can have particle sizes of about 10 nanometers to about 200 micrometers.
- the incorporation of one or more antimicrobial agents into an article or item of protective material provides an additional protection mechanism, acting to inactivate, or suppress the growth of microbial agents, such as bacteria, and viruses, that come into contact with the protective material.
- the antimicrobial agent can be used as a component in, or on the surface of, a variety of articles of manufacture, including articles of protective apparel, such as masks, gloves, clothing, garments or other items intended to protect the wearer or user against harm or injury as caused by exposure to microbial agents.
- the antimicrobial agent can also be used as a component of tampons, incontinence pads, sheets, and curtains.
- the antibacterial agent may also be applied as a coating on the surface of medical devices.
- Medical device refers to any intravascular or extravascular medical devices, medical instruments, foreign bodies including implants and the like.
- medical device also includes surgical or burn dressings, adhesive bandages or any external device that can be applied directed to the skin.
- intravascular medical devices and instruments include balloons or catheter tips adapted for insertion, prosthetic heart valves, sutures, surgical staples, synthetic vessel grafts, stents, stent grafts, vascular or non-vascular grafts, shunts, aneurysm fillers, intraluminal paving systems, guide wires, embolic agents, filters, drug pumps, arteriovenous shunts, artificial heart valves, artificial implants, foreign bodies introduced surgically into the blood vessels or at vascular or non-vascular sites, leads, pacemakers, implantable pulse generators, implantable cardiac defibrillators, cardioverter defibrillators, defibrillators, spinal stimulators, brain stimulators, sacral nerve stimulators, chemical sensors, breast implants, interventional cardiology devices, catheters, and the like.
- one manner of proceeding provides a method of attaching a dialdehyde polysaccharide to a surface, the method comprising placing a dispersion of dialdehyde polysaccharide in water on the surface for a period of time sufficient for at least a portion of the dialdehyde polysaccharide to be adsorbed by the surface; and drying the surface at a temperature of from about 5O 0 C to about 15O 0 C.
- the thus applied dialdehyde polysaccharide functions to kill both bacteria and viruses that come into contact with the surface.
- a composition comprising the antimicrobial agent may be used in a filter.
- the dialdehyde polysaccharides (that are obtained by the oxidation of the polysaccharides) and/or the dialdehyde starch in a suspension of water may be disposed on a porous substrate such as for example, a mesh, a gauze, a porous paper, a weave, a textile, or the like.
- the porous substrate may comprise a polymer, a metal, a ceramic, or a combination comprising a polymer, a metal or a ceramic.
- the porous substrate may be then be optionally dried to remove the moisture.
- the porous substrate with the dialdehyde polysaccharides and/or the dialdehyde starch disposed thereon may then be used as a filter.
- the porous substrate can comprise cellulose.
- the porous substrate can comprise oxidized cellulose. Examples of different types of celluloses are provided above.
- the dialdehyde polysaccharides and/or the dialdehyde starch may be disposed upon a porous substrate.
- a cellulose substrate may be subjected to oxidation to form a layer of dialdehyde polysaccharides on the surface.
- polysaccharides can be oxidized with oxidizers; the oxidizers being alkalis, alkaline earth and transition metal salts of, for example, periodate, hypochlorite, perbromate, chlorite, chlorate, hydrogen peroxide, peracetic acid and combinations comprising at least one of the foregoing oxidizers.
- oxidizers being alkalis, alkaline earth and transition metal salts of, for example, periodate, hypochlorite, perbromate, chlorite, chlorate, hydrogen peroxide, peracetic acid and combinations comprising at least one of the foregoing oxidizers.
- the cellulose substrate may be exposed to the oxidizing agent for a period of time effective to form a layer of dialdehyde polysaccharide (as shown in equation I above) on the surface.
- the total amount of time for the oxidation may be about 10 minutes to about 5 hours.
- a fibrous substrate comprising cellulose subjected to oxidation may subsequently be woven to form a weave or a textile that can be used as a filter.
- a filter that comprises dialdehyde polysaccharides can comprise a plurality of layers that can be physically separated.
- the dialdehyde polysaccharide is generally the outermost layer of the filter that will be contacted by bacteria and viruses.
- a filter can comprise a layer of dialdehyde polysaccharides that is covalently bonded (reacted) with the substrate.
- the substrate and the layer form a single unitary indivisible structure. This structure cannot be physically separated without undergoing some form of mechanical, thermal and/or chemical degradation.
- only a portion of the substrate can be converted to a dialdehyde polysaccharide upon oxidation.
- the entire substrate can be converted to a dialdehyde polysaccharide upon oxidation.
- the filter can comprise pores that are in the micrometer range or in the nanometer range.
- the pores have an average pore size of about 50 to about 2,500 nanometers, specifically about 100 to about 1,500 nanometers, and more specifically about 150 to about 1,000 nanometers.
- a composition comprising the antimicrobial agent may also contain additives such as pigments, fragrances, anticorrosion agents, stabilizers such as triethylene glycol, and surfactants.
- additives such as pigments, fragrances, anticorrosion agents, stabilizers such as triethylene glycol, and surfactants.
- surfactants include quaternary ammonium compounds, nonionic, and anionic surfactants. Quaternary ammonium compounds not only function as surfactants but aid in antimicrobial activity. Nonionic surfactants can provide increased stability to the antimicrobial composition.
- nonionic surfactants include those selected from the group consisting of water insoluble alcohols, for example, octanol, decanol, dodecanol, and the like; phenols, for example, octyl phenol, nonyl phenol, and the like; and ethoxylates of the above-mentioned alcohols and phenols, for example, ethoxylates having from about 1 to about 10 moles of ethylene oxide per mole of alcohol or phenol.
- Other nonionic surfactants that can be used include ethylene oxide/propylene oxide block copolymers. When surfactants are employed they can comprise about 0 to about 89 wt%, preferably about 1 to about 50 wt% of the composition.
- Table 1 lists three strains of Gram negative bacteria, three strains of Gram positive bacteria, two bacterial viruses, and one human virus that were used in the present Examples.
- the bacterial viruses MS2 and PRDl were supplied at a concentration of 10 9 colony- forming units (cfu) per milliter (ml), and the polio virus was at a concentration of 10 7 plaque-forming units per (pfu)/ml.
- the viruses were each provided by the Department of Microbiology at the University of Florida.
- Table 1 Selected microorganisms
- Bacteria were inoculated into 100 ml of 0.35% Columbia broth, at a concentration of 10 7 cfu/ml, and were incubated at 37 0 C, at 200 rotations per minute (rpm). This process was repeated four times in order to completely remove the broth and traces of nutrients. Finally, the bacteria were re- suspended in sterile deionized water to a final concentration of 10 9 cfu/ml.
- N test is the concentration of the bacteria present in the test samples following either 1 hour or 4 hour incubations.
- DAS Granular dialdehyde starch
- Phosphate buffer saline (PBS) solutions were prepared and the pH of the PBS solutions, ranging from about 2.8 to about 8.7, was adjusted using HCl/NaOH.
- PBS Phosphate buffer saline
- the DAS samples were sonicated for about 1 hour prior to initiating the experiments unless otherwise noted.
- viruses including MS2, PRDl and Polio, DAS samples were not sonicated.
- the DAS aqueous suspension was acidic.
- additional experiments were conducted. The effect of pH on the log reduction (inactivation) of bacteria was studied using both PBS and DAS, as shown in Figures 1-4.
- Figures 1 and 3 show the effect of the pH of PBS on the log reduction of both Gram-negative and Gram-positive bacteria respectively
- Figures 2 and 4 show the effect of the pH of DAS on the log reduction of both Gram-negative and Gram- positive bacteria respectively.
- PBS can also kill most of the bacteria (with the exception of EF).
- DAS in the base condition demonstrated strong antimicrobial activities against the three Gram-positive bacterial strains and against one Gram- negative bacterial (EC) strain.
- the inactivation pH range of DAS was much wider than the pH range of PBS, as demonstrated in all three-Gram positive strains and one Gram-negative strain (EC).
- the effect of DAS pH on the inactivation of bacteria may be related to the effect of pH on the activity of the DAS aldehyde groups. Under mild, more basic conditions, it may take a longer period of time for DAS to cause the inactivation of the bacteria.
- Example 2 Effect of DAS Sonication on Bacterial Inactivation This example was conducted to show the antibacterial activity of sonicated
- the particle size of DAS in the sonicated suspension was in the micrometer range. Once the DAS gel was broken down by the sonication, more aldehydes groups could be exposed to the bacterial, even though the pH values remained almost the same.
- the antimicrobial activity of DAS following sonication was significantly improved, as seen in Figure 7. After 30 minutes of sonication, DAS completely kills the bacteria. As a comparison, while the non-sonicated samples were unable completely inactivate all of the bacteria in one hour, they were able to completely kill (inactivate) the bacteria in a four hour period (data not shown).
- Example 3 Evaluation of DAS Effects on Bacterial Viruses This example was conducted to show the antiviral activity of DAS on bacterial viruses.
- the heated DAS samples were employed.
- the antiviral activities of DAS against two bacterial viruses, PRDl and MS2, are presented in Figures 7 and 8.
- no effect of pH on the antiviral activity of PBS, against these two bacterial viruses were observed.
- DAS was able to completely kill all of the PRDl and MS2 bacteriophage, during an incubation period of 4 hours.
- DAS can also completely kill the MS2 bacteriophage within a period of only one hour.
- a lower level of activity against PRDl was observed.
- DAS has a higher level of activity against PRDl than against MS2 in the one hour test.
- RNA polio, MS2
- PRDl DNA viruses
- This example was conducted to determine the properties of the antimicrobial agent that is produced after heating of the dialdehyde starch in water or after the heating of oxidized corn starch in water. The water was deionized prior to heating with either of the starches.
- the dialdehyde starch heated in water was characterized using gel permeation chromatography to determine the molecular weight. Fourier Transform Infrared Spectrometry and Ultraviolet Visible Spectroscopy were used to determine the structure of the antimicrobial agent.
- the dialdehyde starch was obtained from Sigma (P9265), while the oxidized corn starch was obtained from Grain Processing Corporation, Muscatine, Iowa, USA. Both starches were used without further purification. The difference between the structures of the dialdehyde starch and the oxidized corn starch are shown in the Figure 10. Three grams of the dialdehyde starch were heated in deionized water for two hours each at 9O 0 C to 95 0 C.
- the oxidized starch was heated in deionized water in the same manner. The weight percents were based on the total amount of the oxidized starch and the deionized water. The heating was conducted in an oil bath and the deionized water was refluxed during the heating. The suspension manufactured as a result of the heating was cooled to room temperature. The pH values of the 3% starch suspensions before the cook and after the cook were ca. 3.8 and 3 respectively.
- the solubility of the dialdehyde starch in deionized water was determined by the combination of centrifugation and freeze-drying. Upon dissolution in deionized water, the sample is referred to as the "as-prepared dialdehyde starch aqueous suspension".
- the dialdehyde granular suspensions were centrifuged at 10,000g RCF (relative centrifugal force) at 4°C for 30 minutes to obtain the dialdehyde starch sedimentation fraction and the supernatants.
- the dialdehyde starch sedimentation and the supernatants were freeze-dried for 24 hours, and the solid content in each fraction was determined.
- the solubility was expressed as the weight percentage of the solid in the dialdehyde starch supernatant over total solid weight of dialdehyde starch.
- Molecular weight of the as-received dialdehyde starch and freeze-dried dialdehyde starch from the supernatant of the as-prepared dialdehyde starch aqueous suspension was determined by a gel permeation chromatography (GPC) (PL-GPC, Polymer Laboratories, Amherst, MA) with a differential refractive index detector and three phynogel columns.
- the mobile phase was dimethyl sulfoxide (DMSO) containing 5 millimolar (mM) NaNO 3 at a flow-rate of 0.8 milliliters per minute (ml/min).
- the columns were calibrated with a series of dextran narrow standards (American Polymer Standards Corporation, Mentor, Ohio).
- DAS sample (8 milligrams (mg)) was dissolved in DMSO (4 ml) by heating for 120 minutes in a boiling water bath and the solution was filtrated through a 2.0 ⁇ m filter prior to the GPC analysis.
- Figure 11 (a) and (b) are gel permeation chromatography analysis of the as-received dialdehyde starch and the dialdehyde starch solids from the supernatant.
- Figure 11 (a) is a graph showing the response versus the retention time, while the Figure ll(b) is a graph showing the differential weight fraction versus molecular weight.
- the molecular weight and distribution pattern were similar for the as-received dialdehyde starch as for the supernatant of the as-prepared dialdehyde starch aqueous suspension. Both samples displayed a peak value of molecular weight around 900 Daltons. The lack of a small weight percentage of the high molecular weight portion in the as-received dialdehyde starch was probably due to the fact that the as-received dialdehyde starch was observed not to be dispersed completely during the gel permeation chromatography sample preparation.
- the infrared spectra of the dialdehyde starch solids were obtained by a Thermo electron magna 760 FTIR with a DTGS detector in a diffuse reflection mode using 128 scans at resolution of 4 cm "1 . Even though the degradation of the dialdehyde starch during cooking was found to be limited, as the color of the dialdehyde starch aqueous suspension changed to yellow, chemical changes may have taken place as indicated in Figure 12.
- the Figure 12 shows the FTIR spectra of the as-received dialdehyde starch granule, a freeze dried sample of the as-prepared 3% dialdehyde starch aqueous supernatant and a sample comprising the sedimentation after centrifugation.
- dialdehyde starch samples had a characteristics absorption band around 1734cm "1 in the FTIR spectra, revealing the stretching vibration of the carbonyl group. There was a new band around 1693cm “1 and 1716cm “1 for the dialdehyde starch aqueous suspension supernatant and sedimentation respectively.
- the FTIR spectra of polyglutaradehyde showed bands at 1720 and 1680 cm "1 .
- the 1720 cm "1 absorbance peak was assigned to the nonconjugated aldehyde or carboxylic acid and the 1680 cm "1 was assigned to the conjugated aldehyde.
- the formation of the conjugated aldehdye and carboxylic acid of the dialdehyde starch aqueous suspension may be formed by the ⁇ -elimination and Cannizzaro reaction respectively.
- the UV- Vis spectra of the dialdehyde starch suspensions and the dialdehyde starch solids were obtained with a Perkin-Elmer Lambda 800 UV-VIS spectrometer in the transmission and reflectance modes respectively. Quartz cuvettes were used for the suspension measurement.
- Figure 13(a) is a UV- Vis spectra of the dialdehyde starch samples taken in the reflectance mode for as-received dialdehyde starch.
- Figure 13(b) is a UV- Vis spectra of the freeze-dried sample of the 3% as- prepared dialdehyde starch aqueous supernatant taken in the reflectance mode.
- Figure 13(d) is a UV- Vis spectra taken in the transmission mode of the 0.3% dialdehyde starch granular suspension. For the suspensions, no absorbance peaks were observed for the dialdehyde starch granular suspension. This result was probably caused by the sedimentation of the dialdehyde starch granules.
- a strong absorbance peak at 238 nanometer (nm) wavelength was exhibited in the 0.03% dialdehyde starch aqueous suspension supernatant.
- a strong peak at 246 nm and a weak peak at 300 nm were observed in the reflectance mode of the freeze- dried 3% dialdehyde starch aqueous suspension supernatant and as-received dialdehyde starch granule respectively.
- the commercial glutaradehyde suspension exhibits two absorption maxima in the range of 225 to 245 nm and 270 to 290 nm, commonly at 235 nm and 280 nm. After carefully purification, the absorption at 235 nm can be eliminated.
- the experimental setup is shown in the Figure 14. As demonstrated in Figure 14, the experimental set-up had two components. In one set-up, the control had no filter, while the alternative setup was conducted with a filter. Pressure drop, physical removal efficiency (PRE), viable removal efficiency (VRE) and infectivity of virus on the filter were obtained.
- PRE was determined as shown in the Equation (II) below: where N E is the number of particles entering the filter and N p is the number of particles penetrating the filter.
- VRE was determined by counting plaques of virus collected from control and experimental impingers as determined by the Equation (HI). where C ctr is the number of virus collected from the control impinger and C test is the number of virus collected from the experimental impinger.
- Infectivity of virus on the filter paper was determined by counting plaques of virus recovered from untreated and treated filter paper.
- the extracted fraction is defined as the ratio of the infectivity count in the extract solution to the total viruses collected on the filter.
- VRE viable removal efficiency
- Extracted fraction is defined as viable count extracted from the filter/viable count collected on the filter (the lower, the better).
- a lower extracted fraction indicates that the collected micro-organisms on the filter are inactivated.
- Higher filter quality indicates that some microbes are inactivated while flying through the filter, i.e., direct contact with the filter surface is not absolutely required.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Filtering Materials (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5186008P | 2008-05-09 | 2008-05-09 | |
| PCT/US2009/043456 WO2009137831A2 (en) | 2008-05-09 | 2009-05-11 | Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2276343A2 true EP2276343A2 (en) | 2011-01-26 |
Family
ID=41265467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09743817A Withdrawn EP2276343A2 (en) | 2008-05-09 | 2009-05-11 | Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the same |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2276343A2 (en) |
| JP (1) | JP2011524338A (en) |
| CN (1) | CN102083310A (en) |
| AU (1) | AU2009244070A1 (en) |
| CA (1) | CA2723414A1 (en) |
| WO (1) | WO2009137831A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2012067201A1 (en) * | 2010-11-19 | 2014-05-19 | 大塚製薬株式会社 | Proteoglycan binding fiber product and method for producing the same |
| CN102600493B (en) * | 2012-03-06 | 2013-12-18 | 四川大学 | Natural pullulan polysaccharide hydrogel wound dressing and preparation method thereof |
| KR101951290B1 (en) * | 2012-04-18 | 2019-02-22 | 롯데정밀화학 주식회사 | Film and method of preparing the same |
| WO2013183049A1 (en) * | 2012-06-04 | 2013-12-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Antiviral application of compositions comprising glucan |
| CN105343870B (en) * | 2015-11-30 | 2018-10-26 | 江苏邦泽生物医药技术股份有限公司 | A kind of keratin nanoparticle and preparation method thereof |
| RU2754067C2 (en) * | 2018-05-18 | 2021-08-25 | Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" | Antimicrobial composition based on polyphenols and polysaccharides, method for its preparation and application |
| DE202020001666U1 (en) | 2020-04-21 | 2020-06-08 | Walther Enßlin | Impregnation of the surface of clothing, protective clothing, tissue gloves against viruses from the droplets in the air we breathe |
| CN111603608B (en) * | 2020-05-15 | 2021-12-10 | 南通大学 | Pullulan-hyaluronic acid-microfiber spinal cord scaffold and preparation method thereof |
| CN116099033A (en) * | 2021-11-11 | 2023-05-12 | 武汉大学 | A kind of carboxymethyl chitin microsphere embolization agent and its modification method and application |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4034084A (en) * | 1974-10-10 | 1977-07-05 | Personal Products Company | Method of inhibiting microbial activity using insoluble dialdehyde polysaccharides |
| CN1056249A (en) * | 1990-05-09 | 1991-11-20 | 纺织服饰用品工业科学生产联合公司 | The preparation methods of biologically active and based on the dressings of this material |
| US5158778A (en) * | 1991-10-16 | 1992-10-27 | Ecolab Inc. | Stable antimicrobial dialdehyde composition and methods of use |
-
2009
- 2009-05-11 WO PCT/US2009/043456 patent/WO2009137831A2/en not_active Ceased
- 2009-05-11 CA CA2723414A patent/CA2723414A1/en not_active Abandoned
- 2009-05-11 CN CN2009801166232A patent/CN102083310A/en active Pending
- 2009-05-11 AU AU2009244070A patent/AU2009244070A1/en not_active Abandoned
- 2009-05-11 JP JP2011508721A patent/JP2011524338A/en not_active Withdrawn
- 2009-05-11 EP EP09743817A patent/EP2276343A2/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2009137831A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102083310A (en) | 2011-06-01 |
| WO2009137831A3 (en) | 2010-02-25 |
| AU2009244070A1 (en) | 2009-11-12 |
| CA2723414A1 (en) | 2009-11-12 |
| JP2011524338A (en) | 2011-09-01 |
| WO2009137831A2 (en) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009137831A2 (en) | Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the same | |
| Gadkari et al. | Green synthesis of chitosan-cinnamaldehyde cross-linked nanoparticles: Characterization and antibacterial activity | |
| Gulati et al. | Antimicrobial textile: recent developments and functional perspective | |
| Pal et al. | Silver-functionalized bacterial cellulose as antibacterial membrane for wound-healing applications | |
| Vimala et al. | Fabrication of curcumin encapsulated chitosan-PVA silver nanocomposite films for improved antimicrobial activity | |
| Je et al. | Chitosan derivatives killed bacteria by disrupting the outer and inner membrane | |
| Villanueva et al. | Antimicrobial activity of starch hydrogel incorporated with copper nanoparticles | |
| Sundaram et al. | Antimicrobial and physicochemical characterization of biodegradable, nitric oxide-releasing nanocellulose–chitosan packaging membranes | |
| Aguda et al. | Recent advances in functionalization of nanotextiles: A strategy to combat harmful microorganisms and emerging pathogens in the 21st century | |
| He et al. | Modified chitosan-based coating/packaging composites with enhanced antibacterial, antioxidant, and UV-resistant properties for fresh food preservation | |
| Jennings et al. | Chitosan Based Biomaterials Volume 1: Fundamentals | |
| Lee et al. | Tannic-acid-enriched poly (vinyl alcohol) nanofibrous membrane as a UV-shie lding and antibacterial face mask filter material | |
| Gargoubi et al. | Enhancing the functionality of cotton fabric by physical and chemical pre-treatments: A comparative study | |
| Dang et al. | Advancements in manufacturing and applications of starch-based antimicrobial materials | |
| CN104546717A (en) | Highly-antibacterial chitosan film-forming agent and preparation method thereof | |
| Elian et al. | Biobased polymer resources and essential oils: a green combination for antibacterial applications | |
| Nam et al. | Brown cotton fibers self-produce Ag nanoparticles for regenerating their antimicrobial surfaces | |
| Mitra et al. | Applications and challenges of smart antibacterial coatings | |
| Razak et al. | Antimicrobial sustainable biopolymers for biomedical plastics applications–an overview | |
| Chiu et al. | Enhancement of antibacterial activity in electrospun fibrous membranes based on quaternized chitosan with caffeic acid and berberine chloride for wound dressing applications | |
| Agarwalla et al. | Antimicrobial coatings: current mechanisms, challenges, and opportunities | |
| US20120114724A1 (en) | Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the same | |
| El Kadib et al. | Functional bio-based chitosan films: from material design to biological properties | |
| Kraskouski et al. | Multifunctional biocompatible films based on pectin‐Ag nanocomposites and PVA: design, characterization and antimicrobial potential | |
| Silva-Castro et al. | Eco-friendly nanocomposites of chitosan with natural extracts, antimicrobial agents, and nanometals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20101108 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SONG, LEE Inventor name: FARRAH, SAMUEL, M. Inventor name: BANEY, RONALD, H. |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20121201 |